AIP
NYMX

Ameritas Investment Partners’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Ameritas Investment Partners’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,482
Closed -$8K – 3288
2021
Q1 		$8K Hold
3,482
– – ﹤0.01% 2934
2020
Q4 		$9K Hold
3,482
– – ﹤0.01% 2853
2020
Q3 		$9K Hold
3,482
– – ﹤0.01% 2784
2020
Q2 		$12K Buy
+3,482
New +$11K ﹤0.01% 2646

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TEE
Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return

Ameritas Investment Partners's NYMX Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Nymox Pharmaceutical Corp (NYMX) in Q2 2021, closing a stake of 3,482 shares — an estimated $8K sold.

Ameritas Investment Partners first reported a position in NYMX in Q2 2020 and held it in 4 quarters. The position peaked at $12K in Q2 2020. 51 funds tracked by Wall St. Rank hold NYMX as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Nymox Pharmaceutical Corp position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,482 Nymox Pharmaceutical Corp shares in Q2 2021, an estimated $8K.
  • Ameritas Investment Partners first reported a position in Nymox Pharmaceutical Corp in Q2 2020 and held it in 4 quarters.
  • Ameritas Investment Partners's Nymox Pharmaceutical Corp position peaked at $12K in Q2 2020.
  • 51 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.